Hydrocortison Dmb (Hydrocortisone)

Hydrocortison Dmb is indicated for several endocrine and inflammatory conditions where glucocorticoid activity is required.

• Replacement therapy for primary or secondary adrenal insufficiency (Addison’s disease).
• Emergency management of acute adrenal crisis.
• Adjunct treatment of inflammatory and autoimmune disorders such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease.
• Short‑term control of severe allergic reactions or asthma exacerbations when systemic glucocorticoid effect is needed.

• Hydrocortison Dmb acts as an agonist of the intracellular glucocorticoid receptor. After oral absorption, the drug‑receptor complex translocates to the nucleus, where it binds glucocorticoid response elements on DNA, modulating transcription of anti‑inflammatory proteins and suppressing pro‑inflammatory cytokine genes. This genomic effect reduces leukocyte migration, stabilizes lysosomal membranes, and diminishes capillary permeability, producing systemic anti‑inflammatory and immunosuppressive actions.

Adverse reactions to Hydrocortison Dmb vary in frequency and severity.

Common

• Increased appetite or weight gain.
• Mild hyperglycemia or elevated blood glucose.
• Fluid retention leading to peripheral edema.
• Mood changes such as irritability or anxiety.
• Gastrointestinal discomfort or dyspepsia.

Serious

• Suppression of the hypothalamic‑pituitary‑adrenal (HPA) axis.
• Severe hyperglycemia or new‑onset diabetes mellitus.
• Osteoporosis with increased fracture risk.
• Opportunistic infections due to immunosuppression.
• Peptic ulcer disease or gastrointestinal bleeding.

Before initiating Hydrocortison Dmb, consider the following safety measures.

• Assess for active infections; glucocorticoids can worsen bacterial, viral, or fungal infections.
• Evaluate blood glucose levels, especially in patients with diabetes or risk factors for hyperglycemia.
• Monitor bone health; long‑term use may increase risk of osteoporosis.
• Use the lowest effective dose for the shortest duration to limit adrenal suppression.
• Counsel patients on signs of adrenal crisis and the need for stress‑dose steroids during illness or surgery.
• Review vaccination status; live vaccines should be avoided while on systemic glucocorticoids.

Hydrocortison Dmb may interact with several drug classes; awareness can prevent adverse outcomes.

Avoid

• Concurrent use of potent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that can increase systemic exposure.
• High‑dose non‑steroidal anti‑inflammatory drugs (NSAIDs) which raise the risk of gastrointestinal ulceration and bleeding.
• Other systemic glucocorticoids, which may amplify immunosuppression and HPA‑axis suppression.

Use with caution

• Antidiabetic agents, as glucocorticoids can raise blood glucose and may require dose adjustments.
• Anticoagulants (e.g., warfarin), because glucocorticoids may affect coagulation parameters.
• Vaccines, particularly live attenuated vaccines, due to reduced immune response.
• Diuretics, which may exacerbate fluid retention and electrolyte disturbances.